Early treatment for anxiety protects kids

The US study in 288 paediatric patients with anxiety (average age 17) showed that those who responded to treatment in the first three months were 80% more likely to be in remission after six years.

However, whether the patients were assigned to cognitive behaviour therapy, sertraline, a combination or pill placebo made no difference to treatment outcomes.

The authors said the study suggested that early clinical improvement provides protection against recurrence of anxiety disorders and